Loomis, Sayles & Company’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Sell
80,405
-31,835
-28% -$7.14M 0.02% 248
2025
Q4
$23.9M Sell
112,240
-41,165
-27% -$8.5M 0.03% 213
2025
Q3
$30.5M Buy
153,405
+4,908
+3% +$915K 0.04% 170
2025
Q2
$25.6M Sell
148,497
-26,416
-15% -$4.3M 0.03% 197
2025
Q1
$27.3M Sell
174,913
-3,986
-2% -$569K 0.04% 193
2024
Q4
$24.6M Sell
178,899
-5,724
-3% -$753K 0.03% 222
2024
Q3
$27.6M Buy
184,623
+63,029
+52% +$8.51M 0.04% 213
2024
Q2
$16.6M Buy
+121,594
New +$16.5M 0.02% 280
2021
Q3
Sell
-179,446
Closed -$23.6M 888
2021
Q2
$23.6M Buy
179,446
+6,862
+4% +$914K 0.03% 284
2021
Q1
$22.2M Buy
172,584
+14,948
+9% +$2.27M 0.03% 273
2020
Q4
$26.3M Buy
157,636
+32,626
+26% +$5.4M 0.03% 229
2020
Q3
$19.3M Sell
125,010
-1,380
-1% -$198K 0.03% 240
2020
Q2
$18.7M Buy
126,390
+9,795
+8% +$1.34M 0.03% 227
2020
Q1
$13.1M Sell
116,595
-1,286
-1% -$167K 0.03% 246
2019
Q4
$16.4M Sell
117,881
-8,986
-7% -$998K 0.03% 256
2019
Q3
$12.2M Buy
126,867
+25,664
+25% +$2.86M 0.02% 302
2019
Q2
$11.7M Sell
101,203
-6,141
-6% -$735K 0.02% 314
2019
Q1
$12.6M Sell
107,344
-359
-0.3% -$31.4K 0.02% 307
2018
Q4
$6.75M Buy
107,703
+19,648
+22% +$1.23M 0.02% 381
2018
Q3
$6.24M Buy
+88,055
New +$6.06M 0.01% 452

Other funds holding ASND